Reproduction permitted for personal use only. For reprints and reprint permission, contact

Gentel launches cancer-fighting biomarker kit

Madison, Wis. - The Madison-based Gentel Biosciences, has launched an array kit that offers a new method of profiling the patterns of structures that play a role in various cancers.

Gentel Biosciences, a protein microarray life sciences company, is collaborating with Dr. Brian Haab of the Van Andel Research Institute to introduce the product, which it calls the product the APiX GlycoBiomarker Array Kit.

The new analytics tool, which is based on patent-pending technology licensed from the Van Andel Research Institute, provides a means of profiling the patterns of glycans on serum glycoproteins across various disease states. It will be marketed to oncology researchers around the world.

Related stories

Gentel Biosciences hires VP of commercial operations
Gentel BioSciences appoints Kendrick-Parker to board

Gentel Biosciences adds two South African scientists to Advisory Board

-Add Your Comment


Comment Policy: WTN News accepts comments that are on-topic and do not contain advertisements, profanity or personal attacks. Comments represent the views of the individuals who post them and do not necessarily represent the views of WTN Media or our partners, advertisers, or sources. Comments are moderated and are not immediately posted. Your email address will not be posted.

WTN Media cannot accept liability for the content of comments posted here or verify their accuracy. If you believe this comment section is being abused, contact

WTN Media Presents